Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.

PloS one - 1 Jan 2018

Ostendorf Benjamin N, Flenner Eva, Flörcken Anne, Westermann Jörg

Abstract excerpt

Recent reports have revealed myelodysplastic syndromes (MDS) to arise from cancer stem cells phenotypically similar to physiological hematopoietic stem cells. Myelodysplastic hematopoiesis maintains a hierarchical organization, but the proportion of several hematopoietic compartments is skewed and multiple surface markers are aberrantly expressed. These aberrant antigen expression patterns hold diagnostic and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Differentiation

Share to Hematopoietic Stem Cells

Share to Myelodysplastic Syndromes

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 29799854
DOI: 10.1371/journal.pone.0197823
PMCID: PMC5969762

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.PMID 29799854Read ↗

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsSemantic proximity Read ↗

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionSemantic proximity Read ↗

The Multifaceted Nature of Myelodysplastic Syndromes: Clinical, Molecular, and Biological Prognostic FeaturesSemantic proximity Read ↗

Myelodysplastic syndromes.Semantic proximity Read ↗

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeSemantic proximity Read ↗

Stem cell concepts in myelodysplastic syndromes: lessons and challenges.Semantic proximity Read ↗

Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?Semantic proximity Read ↗

Myelodysplastic syndrome is not merely “preleukemia”Semantic proximity Read ↗

MDS: A Stem Cell Disorder—But What Exactly Is Wrong with the Primitive Hematopoietic Cells in This Disease?Semantic proximity Read ↗

Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.Semantic proximity Read ↗

Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.Semantic proximity Read ↗

The myelodysplastic syndrome as a prototypical epigenetic diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.